
Advances in our understanding of the key zzso of chronic inflammation and tissue damage in zzso arthritis zzso have fostered the development of targeted therapies and greatly expanded the available treatment zzso zzso a soluble human fusion protein that selectively zzso the zzso signal required for full zzso zzso is approved for the treatment of moderate to severe zzso in the United States, Canada, and the European zzso This review zzso the data on efficacy zzso activity, quality of life, prevention of structural zzso and safety from zzso clinical trials of zzso plus zzso in patients with: zzso active zzso and an inadequate response to zzso who are zzso to biological zzso zzso zzso and zzso zzso early zzso with poor zzso zzso Novel imaging outcomes and biological changes induced by zzso treatment are also briefly zzso zzso use of zzso as a zzso biological therapy is discussed in light of the current recommendations and zzso 

